A citation-based method for searching scientific literature

Mara-Luciana Floare, Scott P Allen. Neurosci Insights 2020
Times Cited: 6







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Rudolf C Hergesheimer, Anna A Chami, Denis Reis de Assis, Patrick Vourc'h, Christian R Andres, Philippe Corcia, Débora Lanznaster, Hélène Blasco. Brain 2019
90
50

C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.
Scott P Allen, Benjamin Hall, Ryan Woof, Laura Francis, Noemi Gatto, Allan C Shaw, Monika Myszczynska, Jordan Hemingway, Ian Coldicott, Amelia Willcock,[...]. Brain 2019
35
50

TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response.
Peng Wang, Jianwen Deng, Jie Dong, Jianghong Liu, Eileen H Bigio, Marsel Mesulam, Tao Wang, Lei Sun, Li Wang, Alan Yueh-Luen Lee,[...]. PLoS Genet 2019
94
50

TDP-43 proteinopathies: a new wave of neurodegenerative diseases.
Eva Maria Johanna de Boer, Viyanti K Orie, Timothy Williams, Mark R Baker, Hugo M De Oliveira, Tuomo Polvikoski, Matthew Silsby, Parvathi Menon, Mehdi van den Bos, Glenda M Halliday,[...]. J Neurol Neurosurg Psychiatry 2020
72
50

Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis.
Scott P Allen, Benjamin Hall, Lydia M Castelli, Laura Francis, Ryan Woof, Alexandros P Siskos, Eirini Kouloura, Elizabeth Gray, Alexander G Thompson, Kevin Talbot,[...]. Brain 2019
46
33

Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts.
Heather Mortiboys, Kelly Jean Thomas, Werner J H Koopman, Stefanie Klaffke, Patrick Abou-Sleiman, Simon Olpin, Nicholas W Wood, Peter H G M Willems, Jan A M Smeitink, Mark R Cookson,[...]. Ann Neurol 2008
264
33

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies.
Chantal B Lucini, Ralf J Braun. Biomedicines 2021
6
33

The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.
Wenzhang Wang, Luwen Wang, Junjie Lu, Sandra L Siedlak, Hisashi Fujioka, Jingjing Liang, Sirui Jiang, Xiaopin Ma, Zhen Jiang, Edroaldo Lummertz da Rocha,[...]. Nat Med 2016
199
33


TDP-43 post-translational modifications in health and disease.
Emanuele Buratti. Expert Opin Ther Targets 2018
70
33

The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies.
Myungjin Jo, Shinrye Lee, Yu-Mi Jeon, Seyeon Kim, Younghwi Kwon, Hyung-Jun Kim. Exp Mol Med 2020
48
33

TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
Ju Gao, Luwen Wang, Tingxiang Yan, George Perry, Xinglong Wang. Mol Cell Neurosci 2019
31
33

Updated TDP-43 in Alzheimer's disease staging scheme.
Keith A Josephs, Melissa E Murray, Jennifer L Whitwell, Nirubol Tosakulwong, Stephen D Weigand, Leonard Petrucelli, Amanda M Liesinger, Ronald C Petersen, Joseph E Parisi, Dennis W Dickson. Acta Neuropathol 2016
185
33

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Manuela Neumann, Deepak M Sampathu, Linda K Kwong, Adam C Truax, Matthew C Micsenyi, Thomas T Chou, Jennifer Bruce, Theresa Schuck, Murray Grossman, Christopher M Clark,[...]. Science 2006
33

TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.
Brian S Johnson, David Snead, Jonathan J Lee, J Michael McCaffery, James Shorter, Aaron D Gitler. J Biol Chem 2009
505
33

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice.
Nirma D Perera, Doris Tomas, Nayomi Wanniarachchillage, Brittany Cuic, Sophia J Luikinga, Valeria Rytova, Bradley J Turner. Neurobiol Dis 2021
6
33

TARDBP mutations in Parkinson's disease.
Sruti Rayaprolu, Shinsuke Fujioka, Sharleen Traynor, Alexandra I Soto-Ortolaza, Leonard Petrucelli, Dennis W Dickson, Rosa Rademakers, Kevin B Boylan, Neill R Graff-Radford, Ryan J Uitti,[...]. Parkinsonism Relat Disord 2013
33
33

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Tetsuaki Arai, Masato Hasegawa, Haruhiko Akiyama, Kenji Ikeda, Takashi Nonaka, Hiroshi Mori, David Mann, Kuniaki Tsuchiya, Mari Yoshida, Yoshio Hashizume,[...]. Biochem Biophys Res Commun 2006
33

Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.
Magdalini Polymenidou, Clotilde Lagier-Tourenne, Kasey R Hutt, Stephanie C Huelga, Jacqueline Moran, Tiffany Y Liang, Shuo-Chien Ling, Eveline Sun, Edward Wancewicz, Curt Mazur,[...]. Nat Neurosci 2011
807
33




The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS.
Ruxandra Dafinca, Paola Barbagallo, Kevin Talbot. Front Cell Neurosci 2021
18
33

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Ching-Chieh Chou, Yi Zhang, Mfon E Umoh, Spencer W Vaughan, Ileana Lorenzini, Feilin Liu, Melissa Sayegh, Paul G Donlin-Asp, Yu Han Chen, Duc M Duong,[...]. Nat Neurosci 2018
263
33

Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis.
Elisa Rojas-Prats, Loreto Martinez-Gonzalez, Claudia Gonzalo-Consuegra, Nicole F Liachko, Concepción Perez, David Ramírez, Brian C Kraemer, Ángeles Martin-Requero, Daniel I Perez, Carmen Gil,[...]. Eur J Med Chem 2021
12
33

Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
Guangbo Liu, Aaron Byrd, Amanda N Warner, Fen Pei, Eman Basha, Allison Buchanan, J Ross Buchan. Mol Cell Biol 2020
16
33

Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS).
Gabriela Vaca, Loreto Martinez-Gonzalez, Ana Fernandez, Elisa Rojas-Prats, Gracia Porras, Eva P Cuevas, Carmen Gil, Ana Martinez, Ángeles Martin-Requero. J Neurochem 2021
10
33

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger,[...]. Nature 2017
270
33

The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis.
Han-Jou Chen, Jacqueline C Mitchell, Sergey Novoselov, Jack Miller, Agnes L Nishimura, Emma L Scotter, Caroline A Vance, Michael E Cheetham, Christopher E Shaw. Brain 2016
93
33


Changes of activity and isozyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease.
M Bigl, A D Bleyl, D Zedlick, T Arendt, V Bigl, K Eschrich. J Neurochem 1996
27
16


The Peripheral Immune System and Amyotrophic Lateral Sclerosis.
Pamela A McCombe, John D Lee, Trent M Woodruff, Robert D Henderson. Front Neurol 2020
31
16


Systemic and central nervous system metabolic alterations in Alzheimer's disease.
Vera van der Velpen, Tony Teav, Héctor Gallart-Ayala, Florence Mehl, Ioana Konz, Christopher Clark, Aikaterini Oikonomidi, Gwendoline Peyratout, Hugues Henry, Mauro Delorenzi,[...]. Alzheimers Res Ther 2019
62
16

TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency.
Laura J Flinn, Marcus Keatinge, Sandrine Bretaud, Heather Mortiboys, Hideaki Matsui, Elena De Felice, Helen I Woodroof, Lucy Brown, Aimee McTighe, Rosemarie Soellner,[...]. Ann Neurol 2013
52
16

Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models.
Chien Tai Hong, Kai-Yin Chau, Anthony H V Schapira. Sci Rep 2016
30
16

Diagnosis and management of motor neurone disease.
Christopher J McDermott, Pamela J Shaw. BMJ 2008
102
16

Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.
Giulia Ambrosi, Cristina Ghezzi, Sara Sepe, Chiara Milanese, Cesar Payan-Gomez, Cintia R Bombardieri, Marie-Therese Armentero, Roberta Zangaglia, Claudio Pacchetti, Pier Giorgio Mastroberardino,[...]. Biochim Biophys Acta 2014
46
16



Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
Wenzhang Wang, Fanpeng Zhao, Xiaopin Ma, George Perry, Xiongwei Zhu. Mol Neurodegener 2020
237
16



Parkinson's disease.
C E Clarke. BMJ 2007
54
16

Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages.
Per Borghammer, Mallar Chakravarty, Kristjana Yr Jonsdottir, Noriko Sato, Hiroshi Matsuda, Kengo Ito, Yutaka Arahata, Takashi Kato, Albert Gjedde. Brain Struct Funct 2010
103
16


Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease.
Zhi Yao, Sonia Gandhi, Victoria S Burchell, Helene Plun-Favreau, Nicholas W Wood, Andrey Y Abramov. J Cell Sci 2011
47
16

Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
Csaba Konrad, Hibiki Kawamata, Kirsten G Bredvik, Andrea J Arreguin, Steven A Cajamarca, Jonathan C Hupf, John M Ravits, Timothy M Miller, Nicholas J Maragakis, Chadwick M Hales,[...]. Mol Neurodegener 2017
36
16

Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.
Elena A Kosenko, Lyudmila A Tikhonova, Carmina Montoliu, George E Barreto, Gjumrakch Aliev, Yury G Kaminsky. Front Neurosci 2018
14
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.